Salmen, Natasha L.
Menage, Klarens
Baumann, Anthony N.
Curtis, Deven P.
Brodell, Robert T.
Article History
Received: 27 January 2024
Revised: 27 January 2024
Accepted: 9 February 2024
First Online: 30 March 2024
Declarations
:
: Robert Brodell, M.D. discloses the following potential conflicts of interest: Advisory boards: Novan and Amgen. Research funding: Pfizer, Novartis, and Sanofi. Stock: Veragen, Inc. Natasha Salmen, Klarens Menage, Anthony Baumann, and Deven Curtis have no conflicts to disclose.